Conservative regimen for chronic critical limb ischemia

Journal of the Medical Association of Thailand

Volumn 87, Issue 3, 2004, Pages 310-318

  Stapanavatr, Waigoon ^a   Ungkittpaiboon, Withoon ^a   Karnjanabatr, Burapa ^a  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

Author keywords

Cilostazol; Conservative Regimen; Critical Limb Ischemia

Indexed keywords

CILOSTAZOL; TETRAZOLE DERIVATIVE;

AMPUTATION; ARTICLE; CHI SQUARE DISTRIBUTION; CHRONIC CRITICAL LIMB ISCHEMIA; CLAUDICATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIET THERAPY; ENDARTERECTOMY; FEMALE; FITNESS; HEART FUNCTION; HUMAN; KINESIOTHERAPY; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POSTOPERATIVE COMPLICATION; REGISTER; SMOKING CESSATION; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; VEGETARIAN DIET; WALKING; ISCHEMIA; LEG; PRACTICE GUIDELINE; SMOKING; VASCULARIZATION;

CHI-SQUARE DISTRIBUTION; DIET, VEGETARIAN; EXERCISE THERAPY; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; PRACTICE GUIDELINES; REGISTRIES; SMOKING; TETRAZOLES; TREATMENT OUTCOME;

EID: 2642522066     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beard JD. Recommendations for the management of chronic critical lower limb ischemia. Eur J Vasc Endovasc Surg 1996; 12: 131-5.
2. Pedersen AE, Olsen BB, Krasnik M, et al. Halving the number of leg amputations: The influence of infrapopliteal bypass. Eur J Vasc Surg 1994; 8: 26-30.
3. Lindholt JS, Bövling S, Fasting H, Henneberg EW. Vascular surgery reduces the frequency of lower limb major amputations. Eur J Vasc Surg 1994; 8: 31-5.
4. Luther M. The influence of arterial reconstructive surgery on the outcome of critical leg ischemia. Eur J Vasc Surg 1994; 8: 682-9.
5. Collin J. Avoiding amputation. Br Med J 1992; 304: 856-7.
6. Michaels JA, Rutter P, Collin J, Legg FM, Galland RB. Relation between rates of leg amputation and distal arterial reconstructive surgery. Br Med J 1994; 309: 1479-80.
7. Tyrrell MR, Wolfe JHN for the Joint Vascular Research Group. Critical leg ischemia: An appraisal of clinical definitions. Br J Surg 1993; 80: 177-80.
8. Dawson I, Bockel van JH. Reintervention and mortality after infrainguinal reconstructive surgery for leg ischaemia. Br J Surg 1999; 86: 38-44.
9. Taylor LM, Porter JM. Natural history and non-operative treatment of chronic lower extremity ischemia. In Rutherford RB (ed): Vascular surgery. Philadelphia: WB Saunders Company; 1995: 755.
10. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
11. Killewich LA, Gardner AW, Macko RF, et al. Progressive intermittent claudication is associated with impaired fibrinolysis. J Vasc Surg 1998; 27: 645-50.
12. Konkle BA, Kollros PR, Kelly MD. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression: Interaction with cAMP and protein kinase C-mediated pathways. J Biol Chem 1990; 265: 21867-73.
13. Smith FB, Lowe GDO, Lee AJ, Rumley A, Leng GC, Fowkes FGR. Smoking, hemorheologic factors, and progression of peripheral arterial disease in-patients with claudication. J Vasc Surg 1998; 28: 129-35.
14. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000; 109: 523-30.
15. Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988; 36: 313-20.
16. Haslam RJ, Dickinson NT, Jang EK. Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 1999; 82: 412-23.
17. Faglia E, Favales F, Quarantiello A, et al. Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers. Diabetes Care 1998; 21: 625-30.
18. Pina IL, Bove AA. Role of exercise in peripheral vascular disease. In Kerstein MD, White JV (ed). Alternatives to open vascular surgery. Pennsylvania: JB Lippincott Company; 1995.
19. Bodily KC, Burgress EM. Contralateral limb and patient survival after leg amputation. Am J Surg 1983; 146: 280-2.
20. Johnson JA, Cogbill TH, Strutt PJ, Gunderson AL. Wound complications after infrainguinal bypass. Arch Surg 1988; 123: 859-62.
21. Edwards JM, Taylor LM, Porter JM. Limb salvage in end-stage renal disease (ESRD). Arch Surg 1988; 123: 1164-8.
22. Tarry WC, Walsh DB, Birkmeyer NJO, et al. Fate of the contralateral leg after infrainguinal bypass. J Vasc Surg 1998; 27: 1039-48
23. Volger OL, Mensink RP, Plat J, et al. Dietary vegetable oil and wood derived plant stanol esters reduce athrosclerotic lesion size and severity in apoE3-Leiden transgenic mice. Atherosclerosis 2001; 157: 375-81.
24. Efendy JL, Simmons DL, Campbell GR, Campbell JH. The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis. Atherosclerosis 1997; 132: 37-42.
25. Tell GS, Evans GW, Folsom AR, et al. Dietary fat intake and carotid artery wall thickness: The atherosclerosis risk in communities (ARIC) study. Am J Epidermiol 1994; 139: 979-89.
26. Key TJ, Thorogood M, Appleby PN, Burr ML. Dietary habits and mortality in 11,000 vegetarians and health consciuos people: Results of a 17 year follow-up. BMJ 1996; 313: 775-9.
27. Yang HT, Ogilvie RW, Terjung RL. Training Increases collateral-dependent muscle blood flow in aged rats. Am J Physiol 1995; 268: H1174-80.
28. Walker RD, Nawaz S, Wilkinson CH, et al. Influence of upper and lower limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication. J Vasc Surg 2000; 31: 662-9.
29. Okuda Y, Kimura Y, Yamashita K. Cilostazol. Cardiovasc Drug Rev 1993; 11: 451-65.
30. Igawa T, Tani T, Chijiwa T, et al. Potentiation of antiplatelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res 1990; 57: 617-23.
31. Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 1985; 35: 1144-9.
32. Takahashi S, Oida K, Fujiwara R, et al. Effect of cilostazol, a cyclic AMP phosphodiesterase inhitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 1992; 20: 900-6.
33. Tsang GMK, Sanghera K, Gosling P, et al. Pharmacological reduction of the systemically damaging effects of local ischemia. Eur J Vasc Surg 1994; 8: 205-8.
34. Beebe HG, Dawson DL, Cutler BS, et al. A new pharmacological treatment for intermittent claudication. Arch Intern Med 1999; 159: 2041-50.